tetano
Editor, Senior Moderator
Brain Sci
. 2023 Jan 12;13(1):131.
doi: 10.3390/brainsci13010131.
Effects of COVID-19 on Synaptic and Neuronal Degeneration
Mohammed S Alqahtani[SUP] 1 2 [/SUP], Mohamed Abbas[SUP] 3 4 [/SUP], Mohammad Y Alshahrani[SUP] 5 [/SUP], Khulud Alabdullh[SUP] 6 [/SUP], Amjad Alqarni[SUP] 1 [/SUP], Fawaz F Alqahtani[SUP] 7 [/SUP], Layal K Jambi[SUP] 8 [/SUP], Adnan Alkhayat[SUP] 9 [/SUP]
Affiliations
Abstract
Neurons are the basic building blocks of the human body's neurological system. Atrophy is defined by the disintegration of the connections between cells that enable them to communicate. Peripheral neuropathy and demyelinating disorders, as well as cerebrovascular illnesses and central nervous system (CNS) inflammatory diseases, have all been linked to brain damage, including Parkinson's disease (PD). It turns out that these diseases have a direct impact on brain atrophy. However, it may take some time after the onset of one of these diseases for this atrophy to be clearly diagnosed. With the emergence of the Coronavirus disease 2019 (COVID-19) pandemic, there were several clinical observations of COVID-19 patients. Among those observations is that the virus can cause any of the diseases that can lead to brain atrophy. Here we shed light on the research that tracked the relationship of these diseases to the COVID-19 virus. The importance of this review is that it is the first to link the relationship between the Coronavirus and diseases that cause brain atrophy. It also indicates the indirect role of the virus in dystrophy.
Keywords: CNS inflammatory diseases; COVID-19; Parkinson’s disease; brain atrophy; cerebrovascular diseases; demyelinating disorders; peripheral neuropathy.
. 2023 Jan 12;13(1):131.
doi: 10.3390/brainsci13010131.
Effects of COVID-19 on Synaptic and Neuronal Degeneration
Mohammed S Alqahtani[SUP] 1 2 [/SUP], Mohamed Abbas[SUP] 3 4 [/SUP], Mohammad Y Alshahrani[SUP] 5 [/SUP], Khulud Alabdullh[SUP] 6 [/SUP], Amjad Alqarni[SUP] 1 [/SUP], Fawaz F Alqahtani[SUP] 7 [/SUP], Layal K Jambi[SUP] 8 [/SUP], Adnan Alkhayat[SUP] 9 [/SUP]
Affiliations
- PMID: 36672112
- PMCID: PMC9856402
- DOI: 10.3390/brainsci13010131
Abstract
Neurons are the basic building blocks of the human body's neurological system. Atrophy is defined by the disintegration of the connections between cells that enable them to communicate. Peripheral neuropathy and demyelinating disorders, as well as cerebrovascular illnesses and central nervous system (CNS) inflammatory diseases, have all been linked to brain damage, including Parkinson's disease (PD). It turns out that these diseases have a direct impact on brain atrophy. However, it may take some time after the onset of one of these diseases for this atrophy to be clearly diagnosed. With the emergence of the Coronavirus disease 2019 (COVID-19) pandemic, there were several clinical observations of COVID-19 patients. Among those observations is that the virus can cause any of the diseases that can lead to brain atrophy. Here we shed light on the research that tracked the relationship of these diseases to the COVID-19 virus. The importance of this review is that it is the first to link the relationship between the Coronavirus and diseases that cause brain atrophy. It also indicates the indirect role of the virus in dystrophy.
Keywords: CNS inflammatory diseases; COVID-19; Parkinson’s disease; brain atrophy; cerebrovascular diseases; demyelinating disorders; peripheral neuropathy.